Drug intelligence / Profile preview

ambroxol

Development stage
Phase 4
Lead developer
Boehringer
Modality
Small Molecules
Administration
Oral, Inhalation, Intravenous
01

Overview

Ambroxol is a small molecule mucolytic and secretolytic agent used primarily for airway secretion clearance therapy in respiratory diseases associated with viscid or excessive mucus. It acts by stimulating the synthesis and release of surfactant from type II pneumocytes, reducing mucus viscosity and promoting mucociliary transport. Ambroxol also enhances ciliary activity through calcium-mediated signaling pathways, increases bicarbonate import to raise cellular pH, and stimulates chloride ion release via activation of anoctamine 1 (ANO1), further improving mucus clearance. Additionally, it has local anesthetic properties that provide pain relief in acute sore throat and may exert analgesic effects by suppressing C-fiber function. Ambroxol is available in various formulations including tablets, syrups, pastilles, inhalation solutions, drops, ampules, and effervescent tablets[1][2][4][5][6].

Brand names
MucosolvanLasolvanMucoangin
Other names
ambroxol hydrochloride
02

Targets

GBA1 (Glucosylceramidase)

Beyond the preview

Go deeper on ambroxol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ambroxol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call